NEW YORK (GenomeWeb News) – Swedish biotech company Cellectricon announced today that contract research organization BioFocus DPI will use its automated patch clamp system, called Dynaflow, in its electrophysiology-based screening programs.
Under the agreement, BioFocus plans to use Cellectricon's high-throughput microfluidic screening platform to improve its research on fast ligand-gated ion channels screening and other ion channel drug discovery approaches. BioFocus VP of Biological Sciences Kate Hilyard said in a statement that the collaboration is expected to help BioFocus increase its throughput and the number of ion channel subtypes it screens.
Financial terms of the agreement were not disclosed.